PureHealth, a healthcare platform in the Middle East, has completed the strategic acquisition of Circle Health Group, an independent hospital operator in the UK.
Founded in 2004, Circle Health mainly offers musculoskeletal rehabilitation, neurological and other hospital services.
Completion of the transaction follows Centene’s decision to divest Circle Health Group to PureHealth in August last year.
This move is a key part of PureHealth's global expansion strategy and demonstrates the company's operational capabilities and commitment to international growth.
The deal, which is valued at approximately $1.2bn before debt, has received all the regulatory approvals in record time, PureHealth noted.
Circle Health’s acquisition further aligns with the UAE leadership's vision to enhance healthcare services and promote well-being.
PureHealth said that it is focused on improving patient experiences and adopting advanced clinical practices, with the latest deal marking its entry into the UK market.
PureHealth founder and managing director Farhan Malik said: “This acquisition is more than an expansion; it's a significant stride towards establishing PureHealth as a global healthcare platform.”
Malik added: “This move aligns with our vision of pioneering a healthier future for all and underscores our commitment to elevating the global position of Abu Dhabi in the healthcare sector and revolutionising healthcare services globally.
“We look forward to fostering long-term partnerships within the UK’s healthcare ecosystem.”
PureHealth's strategic vision for 2024 includes further expansion, both locally and internationally, building a global healthcare platform.
The company stated that it is advancing its strategy through innovation, technology-driven solutions, and collaboration.
Acquiring Circle Health will also enhance PureHealth's service offerings and position it as a key player in the healthcare industry.
Currently, PureHealth's portfolio includes more than 25 hospitals, 100 clinics, various diagnostic centres, pharmacies, health insurance solutions, and health tech, among others.
PureHealth board of directors and chairman Hamad Al Hammadi said: “This remarkable achievement epitomises PureHealth's operational excellence and strategic adaptability in broadening its international impact.
“After investing in Ardent Health USA, this is PureHealth’s second international acquisition, and we look forward to building our portfolio internationally.”
